Progress in the field of precision medicine has changed the landscape of cancer therapy.
Precision medicine is propelled by technologies that enable molecular profiling, genomic …

Incorporating labile bonds inside polymer backbone and side chains yields interesting
polymer materials that are responsive to change of environmental stimuli. Drugs can be …

Nanotechnology has resulted in materials that have greatly improved the effectiveness of
drug delivery because of their ability to control matter on the nanoscale. Advanced forms of …

Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …

Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free
macromolecular therapeutics) are a group of biologically active compounds that are …

Metastasis is responsible for the majority of breast cancer-related deaths. The metastatic
spread of cancer cells is a complicated process that requires considerable flexibility in the …

Since their initial discovery more than 30 years ago, tumor-homing peptides have become
an increasingly useful tool for targeted delivery of therapeutic and diagnostic agents into …

Targeted drug delivery to specific group of cells offers an attractive strategy to minimize the
undesirable side effects and achieve the therapeutic effect with a lower dose. Both linear …

E-selectin, also known as CD62E, is a cell adhesion molecule expressed on endothelial
cells activated by cytokines. Like other selectins, it plays an important part in inflammation …

Doxorubicin (Dox) was conjugated onto a biodegradable block copolymer methoxy-poly
(ethylene glycol)-block-poly (lactide-co-2, 2-dihydroxymethylpropylene carbonate (mPEG …